Latest Period
Q4 2025
CUSIP: B6S7WD106
Latest Period
Q4 2025
Institutions Reporting
33
Shares (Excl. Options)
3,706,063
Price
$4.60
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
Latest holder context comes from 33 institutions filings for Q4 2025.
What is CUSIP B6S7WD106?
CUSIP B6S7WD106 identifies NYXH - Nyxoah SA - Ordinary Shares, no par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP B6S7WD106:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Cochlear Ltd | 14% | $29,411,833 | 5,847,283 | Cochlear Ltd | 20 Nov 2025 | |||
| CVI Investments, Inc. | 9.9% | $21,261,401 | 4,683,128 | CVI Investments, Inc. | 18 Dec 2025 | |||
| Vestal Point Capital, LP | 3.7% | -42% | $10,599,135 | -$6,932,157 | 1,402,002 | -40% | Vestal Point Capital, LP | 30 Jun 2025 |
As of 31 Dec 2025, 33 institutional investors reported holding 3,706,063 shares of Nyxoah SA - Ordinary Shares, no par value (NYXH). This represents 7.8% of the company’s total 47,304,323 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 105,904 | $309,240 | +$299,531 | $2.92 | 4 |
| 2025 Q4 | 3,706,063 | $16,838,080 | +$3,714,494 | $4.60 | 33 |
| 2025 Q3 | 2,929,528 | $13,487,837 | -$5,222,552 | $4.60 | 32 |
| 2025 Q2 | 3,898,868 | $29,174,504 | -$15,533,963 | $7.48 | 31 |
| 2025 Q1 | 5,982,518 | $41,784,716 | -$5,565,414 | $6.98 | 26 |
| 2024 Q4 | 6,777,412 | $54,448,682 | +$20,890,425 | $8.00 | 22 |
| 2024 Q3 | 4,107,120 | $39,127,655 | -$388,257 | $9.55 | 20 |
| 2024 Q2 | 4,195,054 | $29,379,822 | +$10,408,148 | $6.97 | 20 |
| 2024 Q1 | 2,179,876 | $29,294,057 | +$6,508,841 | $13.49 | 19 |
| 2023 Q4 | 2,100,559 | $9,755,983 | -$2,539,640 | $4.64 | 16 |
| 2023 Q3 | 2,582,497 | $18,221,049 | -$421,500 | $7.05 | 17 |
| 2023 Q2 | 2,642,190 | $21,133,729 | +$2,355,981 | $8.01 | 16 |
| 2023 Q1 | 2,370,165 | $17,619,159 | -$413,253 | $7.47 | 18 |
| 2022 Q4 | 2,647,705 | $13,295,065 | -$1,284,349 | $4.99 | 18 |
| 2022 Q3 | 2,861,442 | $18,080,000 | -$1,534,948 | $6.30 | 18 |
| 2022 Q2 | 3,010,010 | $28,121,040 | -$701,953 | $9.39 | 22 |
| 2022 Q1 | 3,087,795 | $59,117,868 | +$7,732,229 | $19.14 | 17 |
| 2021 Q4 | 2,683,795 | $60,937,000 | -$5,528,041 | $23.00 | 16 |
| 2021 Q3 | 2,581,215 | $75,122,000 | +$69,537,255 | $29.24 | 18 |
| 2021 Q2 | 190,951 | $5,752,000 | -$3,402,112 | $30.12 | 1 |
| 2021 Q1 | 303,892 | $7,179,000 | +$178,358 | $23.62 | 1 |
| 2020 Q4 | 296,342 | $5,729,000 | +$3,674,469 | $19.33 | 1 |
| 2020 Q3 | 106,274 | $2,443,000 | +$2,443,000 | $22.99 | 1 |